Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective treatment of atopic dermatitis in 1–3-year-old children and its impact on allergic rhinitis and/or asthma
2012-002412-95Phase 4Completed
- Sponsor
- Skin and Allergy Hospital
- Start
- Jun 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Envarsus XR, hydrocortisone, desonide and tacrolimus in atopic dermatitis (AD), allergic rhinitis (AR) and asthma, sponsored by Skin and Allergy Hospital. Started Jun 2012; status: completed.
02
Drugs
Envarsus XRhydrocortisonedesonidetacrolimus
03
Conditions
atopic dermatitis (AD)allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on 2012-002412-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002412-95.